avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr2
|
ENSMUSG00000021055.15 | Esr2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Esr2 | mm39_v1_chr12_-_76224025_76224039 | -0.19 | 2.6e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_46146558 | 14.25 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr7_+_26819334 | 12.80 |
ENSMUST00000003100.10
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr9_+_46179899 | 12.68 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr9_-_46146928 | 10.92 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr7_+_140343652 | 9.02 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr2_+_172994841 | 7.53 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr11_+_69945157 | 7.31 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr11_-_5865124 | 6.93 |
ENSMUST00000109823.9
ENSMUST00000109822.8 |
Gck
|
glucokinase |
chr9_+_46151994 | 6.79 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr12_+_104304631 | 6.76 |
ENSMUST00000043058.5
ENSMUST00000101078.12 |
Serpina3k
Serpina3m
|
serine (or cysteine) peptidase inhibitor, clade A, member 3K serine (or cysteine) peptidase inhibitor, clade A, member 3M |
chr15_+_76579885 | 6.72 |
ENSMUST00000231028.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr10_+_127702326 | 6.67 |
ENSMUST00000092058.4
|
Rdh16f2
|
RDH16 family member 2 |
chr10_-_128796834 | 6.55 |
ENSMUST00000026398.5
|
Mettl7b
|
methyltransferase like 7B |
chr9_+_46180362 | 6.48 |
ENSMUST00000214202.2
ENSMUST00000215458.2 ENSMUST00000215187.2 ENSMUST00000213878.2 ENSMUST00000034584.4 |
Apoa5
|
apolipoprotein A-V |
chr17_-_46749370 | 6.19 |
ENSMUST00000087012.7
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr17_-_33136021 | 5.98 |
ENSMUST00000054174.9
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr7_+_127400016 | 5.96 |
ENSMUST00000106271.2
ENSMUST00000138432.2 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr7_+_127399776 | 5.91 |
ENSMUST00000046863.12
ENSMUST00000206674.2 ENSMUST00000106272.8 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr2_-_25391729 | 5.67 |
ENSMUST00000015227.4
|
C8g
|
complement component 8, gamma polypeptide |
chr1_-_180021218 | 5.53 |
ENSMUST00000159914.8
|
Coq8a
|
coenzyme Q8A |
chr6_+_90527762 | 5.51 |
ENSMUST00000130418.8
ENSMUST00000032175.11 ENSMUST00000203111.2 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr15_+_76579960 | 5.44 |
ENSMUST00000229679.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr7_-_105249308 | 5.43 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr15_-_82648376 | 5.22 |
ENSMUST00000055721.6
|
Cyp2d40
|
cytochrome P450, family 2, subfamily d, polypeptide 40 |
chr2_+_102536701 | 5.21 |
ENSMUST00000123759.8
ENSMUST00000005220.11 ENSMUST00000111212.8 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr1_+_72863641 | 5.10 |
ENSMUST00000047328.11
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr7_+_127399789 | 5.03 |
ENSMUST00000125188.8
|
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr17_+_32904629 | 4.99 |
ENSMUST00000008801.7
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr3_-_81883509 | 4.98 |
ENSMUST00000029645.14
ENSMUST00000193879.2 |
Tdo2
|
tryptophan 2,3-dioxygenase |
chr5_-_116560916 | 4.95 |
ENSMUST00000036991.5
|
Hspb8
|
heat shock protein 8 |
chr11_+_78389913 | 4.72 |
ENSMUST00000017488.5
|
Vtn
|
vitronectin |
chr7_-_140856642 | 4.66 |
ENSMUST00000080654.7
ENSMUST00000167263.9 |
Cdhr5
|
cadherin-related family member 5 |
chr11_+_101258368 | 4.56 |
ENSMUST00000019469.3
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr17_+_84990541 | 4.50 |
ENSMUST00000045714.15
ENSMUST00000171915.2 |
Abcg8
|
ATP binding cassette subfamily G member 8 |
chr1_-_180021039 | 4.43 |
ENSMUST00000160482.8
ENSMUST00000170472.8 |
Coq8a
|
coenzyme Q8A |
chr11_+_16702203 | 4.43 |
ENSMUST00000102884.10
ENSMUST00000020329.13 |
Egfr
|
epidermal growth factor receptor |
chr7_+_26821266 | 4.37 |
ENSMUST00000206552.2
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr11_-_75313412 | 4.32 |
ENSMUST00000138661.8
ENSMUST00000000769.14 |
Serpinf1
|
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
chr4_+_140970161 | 4.29 |
ENSMUST00000138096.8
ENSMUST00000006618.9 ENSMUST00000125392.8 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr7_-_12732067 | 4.27 |
ENSMUST00000032539.14
ENSMUST00000120903.8 |
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr18_+_36797113 | 4.00 |
ENSMUST00000036765.8
|
Eif4ebp3
|
eukaryotic translation initiation factor 4E binding protein 3 |
chr17_-_56428968 | 3.97 |
ENSMUST00000041357.9
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1 |
chr4_-_61972348 | 3.97 |
ENSMUST00000074018.4
|
Mup20
|
major urinary protein 20 |
chr11_+_97576724 | 3.94 |
ENSMUST00000107583.3
|
Cisd3
|
CDGSH iron sulfur domain 3 |
chr7_+_127399848 | 3.92 |
ENSMUST00000139068.8
|
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr18_+_32064358 | 3.75 |
ENSMUST00000025254.9
|
Lims2
|
LIM and senescent cell antigen like domains 2 |
chr4_-_63072367 | 3.75 |
ENSMUST00000030041.5
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr7_-_140590605 | 3.73 |
ENSMUST00000026565.7
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr4_-_61437704 | 3.65 |
ENSMUST00000095051.6
ENSMUST00000107483.8 |
Mup16
|
major urinary protein 16 |
chr6_-_55152002 | 3.65 |
ENSMUST00000003569.6
|
Inmt
|
indolethylamine N-methyltransferase |
chr2_+_155223728 | 3.64 |
ENSMUST00000043237.14
ENSMUST00000174685.8 |
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr17_-_84990360 | 3.62 |
ENSMUST00000066175.10
|
Abcg5
|
ATP binding cassette subfamily G member 5 |
chr11_-_75313350 | 3.62 |
ENSMUST00000125982.2
ENSMUST00000137103.8 |
Serpinf1
|
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
chr15_+_82338247 | 3.60 |
ENSMUST00000230000.2
|
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr2_-_30084124 | 3.58 |
ENSMUST00000113659.8
ENSMUST00000113660.2 |
Kyat1
|
kynurenine aminotransferase 1 |
chr11_+_115353290 | 3.57 |
ENSMUST00000106532.4
ENSMUST00000092445.12 ENSMUST00000153466.2 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr11_+_75400889 | 3.53 |
ENSMUST00000042972.7
|
Rilp
|
Rab interacting lysosomal protein |
chr5_-_145816774 | 3.52 |
ENSMUST00000035918.8
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr1_+_131725119 | 3.47 |
ENSMUST00000112393.9
ENSMUST00000048660.12 |
Pm20d1
|
peptidase M20 domain containing 1 |
chr17_+_25097199 | 3.46 |
ENSMUST00000050714.8
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr6_+_42222841 | 3.36 |
ENSMUST00000031897.8
|
Gstk1
|
glutathione S-transferase kappa 1 |
chr10_+_87357782 | 3.35 |
ENSMUST00000219813.2
|
Pah
|
phenylalanine hydroxylase |
chr5_-_147259245 | 3.34 |
ENSMUST00000100433.5
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5) decarboxylase |
chr7_-_48497771 | 3.31 |
ENSMUST00000032658.14
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr14_-_30645503 | 3.30 |
ENSMUST00000227995.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr6_+_41279199 | 3.30 |
ENSMUST00000031913.5
|
Try4
|
trypsin 4 |
chr5_+_146016064 | 3.26 |
ENSMUST00000035571.10
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr7_-_46392403 | 3.25 |
ENSMUST00000128088.4
|
Saa1
|
serum amyloid A 1 |
chr8_-_95405234 | 3.24 |
ENSMUST00000213043.2
|
Pllp
|
plasma membrane proteolipid |
chr8_+_105460627 | 3.20 |
ENSMUST00000034346.15
ENSMUST00000164182.3 |
Ces2a
|
carboxylesterase 2A |
chr4_-_148236516 | 3.18 |
ENSMUST00000056965.12
ENSMUST00000168503.8 ENSMUST00000152098.8 |
Fbxo6
|
F-box protein 6 |
chr2_+_58645189 | 3.18 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr17_+_32904601 | 3.18 |
ENSMUST00000168171.8
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr1_+_87998487 | 3.13 |
ENSMUST00000073772.5
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr11_-_59927688 | 3.11 |
ENSMUST00000102692.10
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr10_+_76411474 | 3.10 |
ENSMUST00000001183.8
|
Ftcd
|
formiminotransferase cyclodeaminase |
chr9_-_103107495 | 3.09 |
ENSMUST00000035158.16
|
Trf
|
transferrin |
chr10_+_78410180 | 3.09 |
ENSMUST00000218061.2
ENSMUST00000218787.2 ENSMUST00000105384.5 ENSMUST00000218875.2 |
Ilvbl
|
ilvB (bacterial acetolactate synthase)-like |
chr3_-_98537568 | 3.09 |
ENSMUST00000044094.6
|
Hsd3b5
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 |
chr14_-_30645711 | 3.08 |
ENSMUST00000006697.17
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr14_-_47426863 | 3.07 |
ENSMUST00000089959.7
|
Gch1
|
GTP cyclohydrolase 1 |
chr5_-_145946408 | 3.07 |
ENSMUST00000138870.2
ENSMUST00000068317.13 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr10_-_39901249 | 3.07 |
ENSMUST00000163705.3
|
Mfsd4b1
|
major facilitator superfamily domain containing 4B1 |
chr19_+_4036562 | 3.04 |
ENSMUST00000236224.2
ENSMUST00000236510.2 ENSMUST00000237910.2 ENSMUST00000235612.2 ENSMUST00000054030.8 |
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr9_+_107957621 | 3.04 |
ENSMUST00000035211.14
|
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr9_+_107957640 | 3.03 |
ENSMUST00000162886.2
|
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr2_+_92205651 | 2.99 |
ENSMUST00000028650.9
|
Pex16
|
peroxisomal biogenesis factor 16 |
chr11_+_83637766 | 2.98 |
ENSMUST00000070832.3
|
Wfdc21
|
WAP four-disulfide core domain 21 |
chr18_-_38345010 | 2.98 |
ENSMUST00000159405.3
ENSMUST00000160721.8 |
Pcdh1
|
protocadherin 1 |
chr7_+_26006594 | 2.97 |
ENSMUST00000098657.5
|
Cyp2a4
|
cytochrome P450, family 2, subfamily a, polypeptide 4 |
chr17_-_56424265 | 2.96 |
ENSMUST00000113072.3
|
Plin5
|
perilipin 5 |
chr7_-_3298243 | 2.93 |
ENSMUST00000108653.4
|
Nlrp12
|
NLR family, pyrin domain containing 12 |
chr10_+_75768964 | 2.92 |
ENSMUST00000219839.2
|
Chchd10
|
coiled-coil-helix-coiled-coil-helix domain containing 10 |
chr11_-_5900019 | 2.92 |
ENSMUST00000102920.4
|
Gck
|
glucokinase |
chr7_-_25331168 | 2.89 |
ENSMUST00000205808.2
|
Bckdha
|
branched chain ketoacid dehydrogenase E1, alpha polypeptide |
chr10_+_87357657 | 2.88 |
ENSMUST00000020241.17
|
Pah
|
phenylalanine hydroxylase |
chr7_-_30623592 | 2.86 |
ENSMUST00000217812.2
ENSMUST00000074671.9 |
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr7_+_140415431 | 2.85 |
ENSMUST00000209978.2
ENSMUST00000210916.2 |
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr7_+_140415170 | 2.84 |
ENSMUST00000211372.2
ENSMUST00000026554.11 ENSMUST00000185612.3 |
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr17_-_56424577 | 2.82 |
ENSMUST00000019808.12
|
Plin5
|
perilipin 5 |
chr13_-_53135064 | 2.81 |
ENSMUST00000071065.8
|
Nfil3
|
nuclear factor, interleukin 3, regulated |
chr8_+_107877252 | 2.81 |
ENSMUST00000034400.5
|
Cyb5b
|
cytochrome b5 type B |
chr7_-_99345016 | 2.81 |
ENSMUST00000107086.9
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr9_-_57590926 | 2.80 |
ENSMUST00000034860.5
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr19_-_4548602 | 2.79 |
ENSMUST00000048482.8
|
2010003K11Rik
|
RIKEN cDNA 2010003K11 gene |
chr18_+_60936910 | 2.79 |
ENSMUST00000097563.9
ENSMUST00000050487.16 ENSMUST00000167610.2 |
Cd74
|
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
chr1_+_87983099 | 2.77 |
ENSMUST00000138182.8
ENSMUST00000113142.10 |
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr10_+_128104525 | 2.76 |
ENSMUST00000050901.5
|
Apof
|
apolipoprotein F |
chr2_+_102488985 | 2.72 |
ENSMUST00000080210.10
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr17_-_34219225 | 2.70 |
ENSMUST00000238098.2
ENSMUST00000087189.7 ENSMUST00000173075.3 ENSMUST00000172912.8 ENSMUST00000236740.2 ENSMUST00000025181.18 |
H2-K1
|
histocompatibility 2, K1, K region |
chr11_+_72326337 | 2.69 |
ENSMUST00000076443.10
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr7_-_30754223 | 2.69 |
ENSMUST00000206012.2
ENSMUST00000108110.5 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr17_-_34247016 | 2.69 |
ENSMUST00000236627.2
ENSMUST00000237759.2 ENSMUST00000045467.14 ENSMUST00000114303.4 |
H2-Ke6
|
H2-K region expressed gene 6 |
chr7_+_119125546 | 2.68 |
ENSMUST00000207387.2
ENSMUST00000207813.2 |
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr4_-_107164347 | 2.68 |
ENSMUST00000082426.11
|
Dio1
|
deiodinase, iodothyronine, type I |
chr2_-_173060647 | 2.65 |
ENSMUST00000109116.3
ENSMUST00000029018.14 |
Zbp1
|
Z-DNA binding protein 1 |
chr5_+_35198853 | 2.65 |
ENSMUST00000030985.10
ENSMUST00000202573.2 |
Hgfac
|
hepatocyte growth factor activator |
chrX_-_7547273 | 2.63 |
ENSMUST00000115695.4
|
Magix
|
MAGI family member, X-linked |
chr11_+_100960838 | 2.62 |
ENSMUST00000001802.10
|
Naglu
|
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) |
chr13_-_63036096 | 2.62 |
ENSMUST00000092888.11
|
Fbp1
|
fructose bisphosphatase 1 |
chr2_+_152511381 | 2.59 |
ENSMUST00000125366.8
ENSMUST00000109825.8 ENSMUST00000089059.9 ENSMUST00000079247.4 |
H13
|
histocompatibility 13 |
chr7_-_30754240 | 2.59 |
ENSMUST00000206860.2
ENSMUST00000071697.11 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr19_-_3962733 | 2.58 |
ENSMUST00000075092.8
ENSMUST00000235847.2 ENSMUST00000235301.2 ENSMUST00000237341.2 |
Ndufs8
|
NADH:ubiquinone oxidoreductase core subunit S8 |
chr8_-_122671588 | 2.58 |
ENSMUST00000057653.8
|
Car5a
|
carbonic anhydrase 5a, mitochondrial |
chr7_+_43856724 | 2.57 |
ENSMUST00000077354.5
|
Klk1b4
|
kallikrein 1-related pepidase b4 |
chr16_-_45975440 | 2.55 |
ENSMUST00000059524.7
|
Gm4737
|
predicted gene 4737 |
chr8_+_105573693 | 2.54 |
ENSMUST00000055052.6
|
Ces2c
|
carboxylesterase 2C |
chr17_-_35077089 | 2.54 |
ENSMUST00000153400.8
|
Cfb
|
complement factor B |
chr17_-_35081456 | 2.54 |
ENSMUST00000025229.11
ENSMUST00000176203.9 ENSMUST00000128767.8 |
Cfb
|
complement factor B |
chr1_+_93062962 | 2.54 |
ENSMUST00000027491.7
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr7_-_30754193 | 2.53 |
ENSMUST00000205778.2
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr1_+_133291302 | 2.52 |
ENSMUST00000135222.9
|
Etnk2
|
ethanolamine kinase 2 |
chr7_+_119125443 | 2.52 |
ENSMUST00000207440.2
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr4_+_115156243 | 2.50 |
ENSMUST00000084343.4
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr10_-_81127334 | 2.49 |
ENSMUST00000219479.2
|
Tjp3
|
tight junction protein 3 |
chr9_-_103107460 | 2.49 |
ENSMUST00000165296.8
ENSMUST00000112645.8 |
Trf
|
transferrin |
chr17_+_35780977 | 2.49 |
ENSMUST00000174525.8
ENSMUST00000068291.7 |
H2-Q10
|
histocompatibility 2, Q region locus 10 |
chr7_+_119125426 | 2.48 |
ENSMUST00000066465.3
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr4_+_133280680 | 2.45 |
ENSMUST00000042706.3
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr4_+_134123631 | 2.44 |
ENSMUST00000105869.9
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr14_-_31362909 | 2.44 |
ENSMUST00000022437.16
|
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr14_-_31362835 | 2.43 |
ENSMUST00000167066.8
ENSMUST00000127204.9 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr10_+_75242745 | 2.43 |
ENSMUST00000039925.8
|
Upb1
|
ureidopropionase, beta |
chr6_-_6217021 | 2.42 |
ENSMUST00000015256.15
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chr13_-_41981812 | 2.42 |
ENSMUST00000223337.2
ENSMUST00000221691.2 |
Adtrp
|
androgen dependent TFPI regulating protein |
chr11_-_53321606 | 2.41 |
ENSMUST00000061326.5
ENSMUST00000109021.4 |
Uqcrq
|
ubiquinol-cytochrome c reductase, complex III subunit VII |
chr16_-_18880821 | 2.40 |
ENSMUST00000200568.2
|
Iglc1
|
immunoglobulin lambda constant 1 |
chr2_-_6217844 | 2.39 |
ENSMUST00000042658.5
|
Echdc3
|
enoyl Coenzyme A hydratase domain containing 3 |
chr17_+_35482063 | 2.39 |
ENSMUST00000172503.3
|
H2-D1
|
histocompatibility 2, D region locus 1 |
chr7_-_30755007 | 2.39 |
ENSMUST00000206474.2
ENSMUST00000205807.2 ENSMUST00000039909.13 ENSMUST00000206305.2 ENSMUST00000205439.2 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr6_+_121277693 | 2.38 |
ENSMUST00000142419.2
|
Slc6a13
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 13 |
chr4_-_63073028 | 2.38 |
ENSMUST00000142901.2
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr13_-_41981893 | 2.36 |
ENSMUST00000137905.2
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr9_-_103099262 | 2.36 |
ENSMUST00000170904.2
|
Trf
|
transferrin |
chr7_-_44465998 | 2.35 |
ENSMUST00000209072.2
ENSMUST00000047356.11 |
Atf5
|
activating transcription factor 5 |
chr5_-_120610828 | 2.33 |
ENSMUST00000052258.14
ENSMUST00000031594.13 |
Sdsl
|
serine dehydratase-like |
chr1_-_162687369 | 2.33 |
ENSMUST00000193078.6
|
Fmo1
|
flavin containing monooxygenase 1 |
chr3_+_146302832 | 2.33 |
ENSMUST00000029837.14
ENSMUST00000147409.2 ENSMUST00000121133.2 |
Uox
|
urate oxidase |
chr11_+_75358866 | 2.33 |
ENSMUST00000043598.14
ENSMUST00000108435.2 |
Tlcd2
|
TLC domain containing 2 |
chr2_+_155224105 | 2.32 |
ENSMUST00000134218.2
|
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr11_+_97576619 | 2.32 |
ENSMUST00000107584.8
ENSMUST00000107585.9 |
Cisd3
|
CDGSH iron sulfur domain 3 |
chr7_+_67925718 | 2.32 |
ENSMUST00000210558.2
|
Fam169b
|
family with sequence similarity 169, member B |
chr17_-_57535003 | 2.30 |
ENSMUST00000177046.2
ENSMUST00000024988.15 |
C3
|
complement component 3 |
chr7_-_12731594 | 2.29 |
ENSMUST00000133977.3
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr11_+_98938137 | 2.29 |
ENSMUST00000140772.2
|
Igfbp4
|
insulin-like growth factor binding protein 4 |
chr15_+_10224052 | 2.29 |
ENSMUST00000128450.8
ENSMUST00000148257.8 ENSMUST00000128921.8 |
Prlr
|
prolactin receptor |
chr1_+_88022776 | 2.28 |
ENSMUST00000150634.8
ENSMUST00000058237.14 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr2_+_24970327 | 2.28 |
ENSMUST00000044078.10
ENSMUST00000114380.9 |
Entpd8
|
ectonucleoside triphosphate diphosphohydrolase 8 |
chr9_-_103097022 | 2.27 |
ENSMUST00000168142.8
|
Trf
|
transferrin |
chr17_-_32639936 | 2.27 |
ENSMUST00000170392.9
ENSMUST00000237165.2 ENSMUST00000235892.2 ENSMUST00000114455.3 |
Pglyrp2
|
peptidoglycan recognition protein 2 |
chr15_-_89258034 | 2.27 |
ENSMUST00000228977.2
|
Sco2
|
SCO2 cytochrome c oxidase assembly protein |
chr16_-_10360893 | 2.26 |
ENSMUST00000184863.8
ENSMUST00000038281.6 |
Dexi
|
dexamethasone-induced transcript |
chr18_-_62044871 | 2.25 |
ENSMUST00000166783.3
ENSMUST00000049378.15 |
Ablim3
|
actin binding LIM protein family, member 3 |
chr17_-_35081129 | 2.25 |
ENSMUST00000154526.8
|
Cfb
|
complement factor B |
chr5_+_120614587 | 2.25 |
ENSMUST00000201684.4
ENSMUST00000066540.14 |
Sds
|
serine dehydratase |
chr17_+_47680097 | 2.24 |
ENSMUST00000060752.13
ENSMUST00000119841.8 |
Mrps10
|
mitochondrial ribosomal protein S10 |
chr17_+_56312672 | 2.24 |
ENSMUST00000133998.8
|
Mpnd
|
MPN domain containing |
chr14_+_66208613 | 2.24 |
ENSMUST00000144619.2
|
Clu
|
clusterin |
chr4_+_117109204 | 2.23 |
ENSMUST00000125943.8
ENSMUST00000106434.8 |
Tmem53
|
transmembrane protein 53 |
chr16_+_22737050 | 2.23 |
ENSMUST00000231768.2
|
Fetub
|
fetuin beta |
chr6_+_41331039 | 2.22 |
ENSMUST00000072103.7
|
Try10
|
trypsin 10 |
chr7_-_84254973 | 2.22 |
ENSMUST00000032865.17
|
Fah
|
fumarylacetoacetate hydrolase |
chr4_+_117109148 | 2.21 |
ENSMUST00000062824.12
|
Tmem53
|
transmembrane protein 53 |
chr3_+_94600863 | 2.20 |
ENSMUST00000090848.10
ENSMUST00000173981.8 ENSMUST00000173849.8 ENSMUST00000174223.2 |
Selenbp2
|
selenium binding protein 2 |
chr5_-_135773047 | 2.20 |
ENSMUST00000153399.2
|
Tmem120a
|
transmembrane protein 120A |
chr5_+_137979763 | 2.20 |
ENSMUST00000035390.7
|
Azgp1
|
alpha-2-glycoprotein 1, zinc |
chr1_-_162687254 | 2.19 |
ENSMUST00000131058.8
|
Fmo1
|
flavin containing monooxygenase 1 |
chr5_+_115061293 | 2.19 |
ENSMUST00000031540.11
ENSMUST00000112143.4 |
Oasl1
|
2'-5' oligoadenylate synthetase-like 1 |
chr7_+_44498640 | 2.18 |
ENSMUST00000054343.15
ENSMUST00000142880.3 |
Akt1s1
|
AKT1 substrate 1 (proline-rich) |
chr3_+_137983250 | 2.17 |
ENSMUST00000004232.10
|
Adh1
|
alcohol dehydrogenase 1 (class I) |
chr17_+_34524841 | 2.16 |
ENSMUST00000235530.2
|
H2-Eb1
|
histocompatibility 2, class II antigen E beta |
chr11_+_120421496 | 2.16 |
ENSMUST00000026119.8
|
Gcgr
|
glucagon receptor |
chr8_+_127790772 | 2.16 |
ENSMUST00000079777.12
ENSMUST00000160272.8 ENSMUST00000162907.8 ENSMUST00000162536.8 ENSMUST00000026921.13 ENSMUST00000162665.8 ENSMUST00000162602.8 ENSMUST00000160581.8 ENSMUST00000161355.8 ENSMUST00000162531.8 ENSMUST00000160766.8 ENSMUST00000159537.8 |
Pard3
|
par-3 family cell polarity regulator |
chr8_-_25066313 | 2.15 |
ENSMUST00000121992.2
|
Ido2
|
indoleamine 2,3-dioxygenase 2 |
chr4_-_61259997 | 2.15 |
ENSMUST00000071005.9
ENSMUST00000075206.12 |
Mup14
|
major urinary protein 14 |
chr10_+_93324624 | 2.14 |
ENSMUST00000129421.8
|
Hal
|
histidine ammonia lyase |
chr6_-_6217126 | 2.13 |
ENSMUST00000188414.4
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chr19_-_6887361 | 2.12 |
ENSMUST00000025904.12
|
Prdx5
|
peroxiredoxin 5 |
chr17_-_33166346 | 2.12 |
ENSMUST00000139353.8
|
Cyp4f13
|
cytochrome P450, family 4, subfamily f, polypeptide 13 |
chr15_-_76501525 | 2.11 |
ENSMUST00000230977.2
|
Slc39a4
|
solute carrier family 39 (zinc transporter), member 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 25.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
5.7 | 17.2 | GO:0018931 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
5.1 | 20.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
3.1 | 9.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
2.8 | 8.3 | GO:0009095 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
2.6 | 10.2 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
2.1 | 22.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.0 | 9.8 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.9 | 9.7 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
1.8 | 5.5 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
1.7 | 5.0 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
1.6 | 6.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.6 | 8.0 | GO:0006548 | histidine catabolic process(GO:0006548) |
1.5 | 4.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.5 | 6.0 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
1.5 | 4.4 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
1.4 | 15.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.4 | 4.2 | GO:0042853 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) |
1.3 | 6.6 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.3 | 2.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.3 | 15.3 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
1.3 | 8.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.3 | 3.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.2 | 2.5 | GO:0046226 | coumarin catabolic process(GO:0046226) |
1.2 | 2.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
1.2 | 6.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.2 | 20.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.2 | 3.6 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
1.2 | 8.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.2 | 3.5 | GO:1903000 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
1.1 | 6.5 | GO:0070459 | prolactin secretion(GO:0070459) |
1.1 | 3.2 | GO:0002396 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
1.0 | 5.2 | GO:0034371 | chylomicron remodeling(GO:0034371) |
1.0 | 3.1 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
1.0 | 3.0 | GO:2001293 | fatty-acyl-CoA biosynthetic process(GO:0046949) malonyl-CoA metabolic process(GO:2001293) |
1.0 | 3.0 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
1.0 | 3.0 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
1.0 | 2.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.0 | 4.8 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
1.0 | 5.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.9 | 10.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.9 | 0.9 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.9 | 3.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.9 | 2.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.9 | 2.6 | GO:0006169 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
0.8 | 2.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.8 | 2.5 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.8 | 4.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.8 | 4.1 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.8 | 5.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.8 | 2.4 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.8 | 4.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.8 | 9.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.8 | 3.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.8 | 3.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.7 | 2.9 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 9.6 | GO:0097421 | liver regeneration(GO:0097421) |
0.7 | 5.0 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.7 | 2.9 | GO:0034759 | regulation of iron ion transport(GO:0034756) negative regulation of iron ion transport(GO:0034757) regulation of iron ion transmembrane transport(GO:0034759) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.7 | 2.8 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.7 | 2.1 | GO:0034034 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.7 | 2.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.7 | 5.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.7 | 5.5 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.7 | 1.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.7 | 0.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 4.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.7 | 2.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.7 | 2.0 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
0.7 | 2.6 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.7 | 2.0 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.6 | 1.9 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
0.6 | 8.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.6 | 1.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 1.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 1.9 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
0.6 | 4.9 | GO:0032782 | bile acid secretion(GO:0032782) |
0.6 | 1.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.6 | 3.6 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.6 | 3.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 4.8 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.6 | 1.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 3.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.6 | 4.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.6 | 1.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.6 | 1.8 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.6 | 3.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.6 | 0.6 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.6 | 1.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 2.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.6 | 3.9 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.6 | 5.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.6 | 5.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 1.7 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.5 | 2.7 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.5 | 14.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.5 | 2.2 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.5 | 4.3 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.5 | 1.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 6.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 12.6 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.5 | 1.6 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.5 | 7.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 4.6 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.5 | 5.1 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 2.0 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.5 | 0.5 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.5 | 1.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 1.0 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.5 | 1.5 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.5 | 1.5 | GO:0051878 | lateral element assembly(GO:0051878) |
0.5 | 2.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 4.3 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.5 | 2.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 1.9 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 1.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.5 | 1.4 | GO:0006530 | asparagine catabolic process(GO:0006530) |
0.5 | 0.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 3.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 1.4 | GO:0097212 | cleavage furrow ingression(GO:0036090) lysosomal membrane organization(GO:0097212) |
0.4 | 3.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.4 | 2.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 1.3 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.4 | 1.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.4 | 14.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.4 | 1.3 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.4 | 1.8 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.4 | 3.9 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.4 | 2.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 1.7 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.4 | 1.3 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.4 | 1.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 7.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 1.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.4 | 2.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.4 | 3.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.4 | 3.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 1.6 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.4 | 2.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 11.0 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 2.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.4 | 1.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 3.4 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.4 | 1.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 1.1 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.4 | 17.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 2.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 1.5 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 1.5 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.4 | 5.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 1.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.4 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 1.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.4 | 0.4 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.4 | 4.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 3.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.4 | 1.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 1.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.4 | 1.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 3.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.4 | 1.1 | GO:0042262 | dGTP catabolic process(GO:0006203) DNA protection(GO:0042262) dATP catabolic process(GO:0046061) |
0.3 | 4.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 2.1 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 3.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 21.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 2.3 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 3.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 1.6 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.3 | 1.9 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 1.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.3 | 1.0 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.3 | 1.6 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 1.0 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
0.3 | 3.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 1.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.6 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 0.6 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.3 | 0.3 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.3 | 1.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 9.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 2.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 1.8 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.3 | 1.2 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 1.5 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.3 | 0.9 | GO:0052572 | interleukin-15 production(GO:0032618) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.3 | 0.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 0.3 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.3 | 0.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.9 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.3 | 0.6 | GO:0061017 | hepatoblast differentiation(GO:0061017) |
0.3 | 0.9 | GO:0060540 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) |
0.3 | 1.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.3 | 2.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 0.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.3 | 3.8 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.3 | 1.4 | GO:1905161 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.3 | 3.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 3.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 0.8 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.3 | 4.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 2.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 2.9 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 0.8 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 1.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 2.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 3.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 3.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 2.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.7 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.2 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 1.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 7.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 1.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.7 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.2 | 1.2 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.2 | 1.0 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 1.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 0.7 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 1.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 1.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 1.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 0.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.2 | 0.5 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.5 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 5.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 1.2 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.2 | 0.9 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 1.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.7 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 1.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.9 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.2 | 0.9 | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 1.6 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.2 | 2.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.7 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 1.3 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 1.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.6 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
0.2 | 0.9 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
0.2 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.6 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 2.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 1.9 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.6 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.2 | 1.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 5.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 3.8 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.4 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.2 | 1.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 4.0 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 1.1 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 2.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 2.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 1.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.2 | 0.6 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.2 | 0.6 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.2 | 2.0 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 0.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 | 1.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 1.4 | GO:0061709 | reticulophagy(GO:0061709) |
0.2 | 2.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 7.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 1.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.8 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.2 | 0.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.6 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.2 | 0.6 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 1.4 | GO:0042637 | catagen(GO:0042637) |
0.2 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 1.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.2 | 0.6 | GO:0061646 | positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization(GO:0061646) |
0.2 | 3.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 2.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 0.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 0.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 0.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 0.6 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.2 | 1.3 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 3.3 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 0.4 | GO:0070256 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.2 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 1.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.6 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 2.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.6 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.2 | 1.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 0.9 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.2 | 0.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 1.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.9 | GO:0072014 | proximal tubule development(GO:0072014) |
0.2 | 0.5 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.9 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 1.6 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.2 | 2.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.2 | 0.9 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.2 | 8.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 1.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.9 | GO:0072144 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.2 | 0.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.2 | 0.5 | GO:0021679 | cerebellar molecular layer development(GO:0021679) |
0.2 | 0.5 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.2 | 1.1 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.2 | 0.5 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 1.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 2.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 1.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 1.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
0.2 | 0.3 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.2 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 1.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 1.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 1.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.5 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.2 | 0.8 | GO:0045872 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 4.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 3.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 0.2 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.2 | 1.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.9 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.2 | 0.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.6 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 9.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 1.1 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.3 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.2 | 3.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.8 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.8 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.9 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.2 | 0.6 | GO:0090345 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.2 | 2.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 0.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.2 | 2.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.2 | 0.5 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.1 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 1.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 1.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 1.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.6 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.1 | 1.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 7.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 1.7 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.6 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.1 | GO:0061193 | taste bud development(GO:0061193) |
0.1 | 1.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.4 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.1 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 2.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 2.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.4 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.1 | 3.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 1.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.6 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.1 | 1.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 1.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 1.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 1.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 1.6 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.4 | GO:0070194 | synaptonemal complex disassembly(GO:0070194) |
0.1 | 0.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.5 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.1 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.1 | 1.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 2.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.6 | GO:1904925 | negative regulation of mitochondrial fusion(GO:0010637) chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.1 | 0.6 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.5 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.5 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 1.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 3.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.9 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.6 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.4 | GO:0097402 | neuroblast migration(GO:0097402) |
0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 1.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 2.1 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 1.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.4 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.5 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.1 | 0.5 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.1 | 0.8 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.1 | 0.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 2.7 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 7.8 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 1.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 1.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 1.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.6 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.8 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 1.0 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 1.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 1.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.7 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.1 | 4.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.1 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 1.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.1 | 0.5 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 1.7 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 1.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.6 | GO:0070255 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
0.1 | 0.7 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 2.3 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.5 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.1 | GO:1903412 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
0.1 | 0.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 1.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 1.8 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 5.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 1.2 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.2 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.1 | 0.7 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.4 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.1 | 2.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 2.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.7 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 1.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.4 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.1 | 0.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.1 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
0.1 | 1.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.4 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.1 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.3 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.1 | 0.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.2 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.8 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 1.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 10.2 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 0.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 1.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 1.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.2 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.1 | 0.2 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 0.3 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.1 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 0.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.5 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 3.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.3 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.1 | 0.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.2 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.1 | 0.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 0.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 1.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.2 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
0.1 | 0.9 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 2.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.8 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.1 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.5 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.9 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 1.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 1.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.5 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.2 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.1 | 0.1 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.3 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.1 | 1.4 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.2 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 2.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 1.1 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 2.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 2.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 1.4 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.3 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 2.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.1 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 1.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.4 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 1.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 5.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.2 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.1 | 0.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 1.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.5 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.2 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 1.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 1.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.1 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 1.0 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.3 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.1 | GO:0010728 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0071640 | macrophage inflammatory protein-1 alpha production(GO:0071608) regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
0.1 | 0.2 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.5 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.3 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.1 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.5 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.9 | GO:0060544 | regulation of necroptotic process(GO:0060544) negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.2 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 2.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 1.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 1.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.2 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.1 | 1.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 1.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.1 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.1 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.7 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:1902462 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 1.2 | GO:0023058 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.0 | 0.2 | GO:0090282 | positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.0 | 0.1 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.0 | 0.2 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.0 | 0.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 6.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.9 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.4 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.0 | 1.3 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.1 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 1.2 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.0 | 1.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 2.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.1 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.0 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 1.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.0 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.0 | 0.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.3 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.2 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.0 | 0.0 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.0 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.3 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.0 | 0.7 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 0.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 1.3 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.5 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.0 | 0.6 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.0 | 0.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 1.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 1.0 | GO:0009108 | coenzyme biosynthetic process(GO:0009108) |
0.0 | 0.2 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0042694 | muscle cell fate specification(GO:0042694) |
0.0 | 0.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.0 | 1.5 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.2 | GO:1990839 | response to endothelin(GO:1990839) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.0 | 0.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 1.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 1.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.5 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.3 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.3 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.3 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0015734 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
0.0 | 0.2 | GO:0035813 | regulation of renal sodium excretion(GO:0035813) |
0.0 | 0.1 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.0 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.0 | 0.1 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.0 | 1.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0002856 | negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.0 | 2.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.0 | GO:1904587 | response to glycoprotein(GO:1904587) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.4 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.0 | 0.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 1.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.2 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.1 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.0 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.0 | GO:0072752 | cellular response to rapamycin(GO:0072752) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.0 | 0.3 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.0 | 0.0 | GO:0014862 | regulation of the force of skeletal muscle contraction(GO:0014728) regulation of skeletal muscle contraction by chemo-mechanical energy conversion(GO:0014862) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.5 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.2 | GO:0042428 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.1 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.0 | 0.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.1 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.0 | 0.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.0 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.0 | 0.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.2 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.5 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.0 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0033382 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.0 | 0.0 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.0 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.0 | 0.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 29.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.3 | 27.2 | GO:0042627 | chylomicron(GO:0042627) |
1.2 | 15.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.1 | 2.2 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.9 | 7.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.9 | 11.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 4.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.8 | 10.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.7 | 8.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.7 | 3.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.7 | 0.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 2.7 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.7 | 4.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 17.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 1.9 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.6 | 3.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.6 | 5.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 0.6 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.5 | 2.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 5.3 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.5 | 1.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.5 | 2.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.5 | 9.8 | GO:0045180 | basal cortex(GO:0045180) |
0.5 | 2.5 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.5 | 3.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 6.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 8.2 | GO:0043203 | axon hillock(GO:0043203) |
0.5 | 14.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 4.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.4 | 6.6 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.4 | 4.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 2.1 | GO:0000802 | transverse filament(GO:0000802) |
0.4 | 1.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 12.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 1.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 1.2 | GO:0044317 | rod spherule(GO:0044317) |
0.4 | 1.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 1.9 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.4 | 3.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 3.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 4.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 1.1 | GO:0061474 | phagolysosome membrane(GO:0061474) |
0.3 | 1.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 17.3 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 1.0 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.3 | 3.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 2.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 0.9 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.3 | 1.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 4.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 0.8 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.3 | 0.8 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 1.5 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 8.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 2.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 2.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 1.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 2.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 0.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 2.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 3.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 6.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 0.8 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.2 | 0.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 28.0 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 1.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.5 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.2 | 5.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 30.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 2.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 4.4 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 40.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 0.8 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 2.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 0.6 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 14.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.6 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.1 | 2.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.7 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 10.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.8 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 1.0 | GO:0001652 | granular component(GO:0001652) |
0.1 | 3.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 47.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 2.2 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 2.7 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 4.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.1 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.5 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.1 | 2.4 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 1.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.1 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.1 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 1.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 2.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.0 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 1.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 5.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 3.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.2 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 1.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.1 | 0.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 14.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.3 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.3 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 1.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.2 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 1.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 7.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.3 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 1.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 1.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 1.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.1 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 1.6 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 3.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.0 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 82.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.0 | 1.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 2.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 57.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 11.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 1.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 1.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 1.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 2.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.5 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.5 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 1.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 1.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.0 | GO:0071914 | prominosome(GO:0071914) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.0 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.1 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.0 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 15.7 | GO:0005615 | extracellular space(GO:0005615) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 26.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
5.2 | 20.8 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
4.9 | 29.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.5 | 7.5 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
2.4 | 12.2 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
2.0 | 6.0 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
1.9 | 5.7 | GO:0033971 | hydroxyisourate hydrolase activity(GO:0033971) |
1.8 | 5.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
1.8 | 7.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.5 | 4.6 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
1.5 | 6.0 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
1.5 | 6.0 | GO:0019862 | IgA binding(GO:0019862) |
1.5 | 4.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
1.5 | 10.2 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
1.4 | 4.2 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.4 | 8.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.4 | 8.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.3 | 5.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.3 | 3.9 | GO:0070279 | vitamin B6 binding(GO:0070279) |
1.3 | 48.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.2 | 1.2 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
1.2 | 6.0 | GO:0005186 | pheromone activity(GO:0005186) |
1.2 | 3.6 | GO:0047945 | L-phenylalanine:pyruvate aminotransferase activity(GO:0047312) glutamine-phenylpyruvate transaminase activity(GO:0047316) L-glutamine:pyruvate aminotransferase activity(GO:0047945) |
1.1 | 5.7 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.1 | 4.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.1 | 4.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.1 | 3.3 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
1.0 | 5.2 | GO:0035478 | chylomicron binding(GO:0035478) |
1.0 | 3.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.0 | 5.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.0 | 2.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.0 | 7.8 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
1.0 | 6.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.9 | 1.9 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.9 | 3.7 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.9 | 4.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.9 | 2.7 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.9 | 7.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.9 | 2.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.9 | 2.7 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.9 | 5.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.9 | 2.6 | GO:0004001 | adenosine kinase activity(GO:0004001) |
0.8 | 5.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.8 | 2.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.8 | 2.4 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.8 | 3.2 | GO:0042806 | fucose binding(GO:0042806) |
0.8 | 7.2 | GO:0035473 | lipase binding(GO:0035473) |
0.8 | 9.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 2.4 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
0.8 | 2.3 | GO:0034632 | retinol transporter activity(GO:0034632) |
0.8 | 2.3 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.7 | 3.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.7 | 11.1 | GO:0046977 | TAP binding(GO:0046977) |
0.7 | 2.9 | GO:0004103 | choline kinase activity(GO:0004103) |
0.7 | 4.3 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.7 | 2.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.7 | 2.8 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.7 | 3.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.7 | 6.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 6.9 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.7 | 2.7 | GO:0070404 | NADH binding(GO:0070404) |
0.7 | 4.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.7 | 2.0 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
0.7 | 7.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.6 | 1.9 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.6 | 14.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.6 | 1.9 | GO:0008431 | vitamin E binding(GO:0008431) |
0.6 | 5.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 3.8 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
0.6 | 2.5 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
0.6 | 1.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.6 | 3.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 3.0 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.6 | 3.0 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.6 | 6.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 3.6 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.6 | 2.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.6 | 5.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.6 | 1.8 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.6 | 10.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.6 | 3.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.6 | 2.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.6 | 4.0 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.6 | 3.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.6 | 1.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.6 | 1.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.6 | 22.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.6 | 2.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 1.6 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
0.5 | 1.6 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.5 | 1.6 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
0.5 | 2.6 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.5 | 2.6 | GO:0043546 | molybdenum ion binding(GO:0030151) molybdopterin cofactor binding(GO:0043546) |
0.5 | 1.5 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.5 | 9.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.5 | 2.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.5 | 2.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 1.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.5 | 2.4 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.5 | 1.4 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
0.5 | 1.9 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.5 | 2.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 1.9 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.5 | 3.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.5 | 1.4 | GO:0004067 | asparaginase activity(GO:0004067) |
0.5 | 16.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.5 | 4.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.5 | 2.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.5 | 1.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 12.7 | GO:0001848 | complement binding(GO:0001848) |
0.5 | 1.4 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.4 | 1.3 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.4 | 0.4 | GO:0086062 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.4 | 0.9 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.4 | 4.7 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 2.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 2.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 1.2 | GO:0050354 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
0.4 | 4.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 1.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 2.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 1.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.4 | 1.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 2.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.4 | 4.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 3.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 2.3 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.4 | 3.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 1.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.4 | 1.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.4 | 6.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.4 | 2.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 1.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.4 | 4.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 3.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 3.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.4 | 1.1 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.3 | 1.0 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.3 | 2.0 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.3 | 1.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.3 | 1.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 1.3 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 1.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 1.0 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.3 | 2.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 1.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 3.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 0.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 1.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 0.9 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.3 | 4.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 0.9 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 0.9 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.3 | 3.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 2.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.3 | 0.9 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.3 | 2.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 1.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 2.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.3 | 1.4 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 0.9 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.3 | 1.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 1.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 2.0 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.3 | 1.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.7 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.1 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.3 | 6.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 0.5 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.3 | 0.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.3 | 0.8 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.3 | 1.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 0.8 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.3 | 1.0 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.3 | 4.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 4.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 1.0 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.3 | 2.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.5 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 4.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 2.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 7.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.7 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
0.2 | 0.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 1.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 4.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 1.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 2.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 4.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 6.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 4.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 1.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 2.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 4.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 2.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 2.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 2.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 2.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 1.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 2.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.0 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.2 | 0.6 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.2 | 0.4 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 1.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.0 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.2 | 0.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 1.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 2.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 27.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.6 | GO:0047598 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.2 | 0.7 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.2 | 0.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 2.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.2 | 1.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 2.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 0.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 1.2 | GO:0050610 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.2 | 1.0 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.5 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.2 | 1.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 3.6 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.5 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.2 | 0.5 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.2 | 2.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.5 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) |
0.2 | 1.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.5 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.2 | 0.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.2 | 2.5 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 12.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 2.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 2.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 2.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.6 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 1.7 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.6 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 1.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 6.6 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.4 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 2.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 2.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 11.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 1.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 1.0 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.4 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.1 | 0.4 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 2.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 3.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.5 | GO:0036478 | superoxide dismutase copper chaperone activity(GO:0016532) tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.1 | 24.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.4 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
0.1 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 5.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.6 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 0.5 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.1 | 0.4 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.1 | 2.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.1 | 1.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 2.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.1 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 2.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.6 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 2.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 1.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 8.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.3 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.1 | 1.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 2.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 3.7 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 1.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.4 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.1 | 2.3 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 1.4 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 6.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.5 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.1 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.1 | 1.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 1.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 2.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.3 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.6 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.2 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
0.1 | 0.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.2 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.1 | 0.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 2.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 1.6 | GO:0042166 | acetylcholine-gated cation channel activity(GO:0022848) acetylcholine binding(GO:0042166) |
0.1 | 1.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.8 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 2.3 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.5 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 1.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.1 | 2.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 2.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.7 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.5 | GO:0070290 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 3.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.1 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 2.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 4.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 2.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.2 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) |
0.1 | 0.4 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.1 | 0.2 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.3 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 1.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.1 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.1 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.8 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.1 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.0 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 1.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 2.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 6.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 1.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.1 | GO:0070138 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 4.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.1 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 1.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.2 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.0 | 0.8 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 2.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 2.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 1.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.9 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 1.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 5.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 1.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.7 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.0 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 1.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0001761 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.0 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 1.2 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.4 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.0 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 1.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.2 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.4 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.0 | 0.6 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0098960 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) postsynaptic neurotransmitter receptor activity(GO:0098960) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.1 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.0 | GO:0015651 | organic cation transmembrane transporter activity(GO:0015101) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 2.2 | GO:0022832 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.0 | 0.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 0.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.0 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 11.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 1.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 6.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 5.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 3.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 12.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 17.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 54.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 3.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 4.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 3.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 3.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 4.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 10.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 2.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 2.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 1.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 2.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.0 | 29.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.8 | 52.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.9 | 12.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.9 | 12.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 9.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 6.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 9.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.5 | 4.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 5.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 5.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 4.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 6.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 7.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 8.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 10.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 30.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.4 | 10.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 1.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 3.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 7.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 3.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 7.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 8.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 0.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 5.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 9.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 10.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 4.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 6.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 3.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 4.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 24.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 3.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 0.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 11.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 44.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 0.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 5.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 4.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 8.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 5.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 3.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 2.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 3.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 2.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 8.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 3.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 2.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 5.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 5.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 3.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.4 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 2.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 2.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 7.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 8.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 2.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 5.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 2.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 2.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.8 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 3.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.2 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 4.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 1.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |